COLO B Coloplast A/S Class B

Coloplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)

Coloplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)

The event will take place on Thursday, 6 June 2024 at Coloplast’s Headquarters

Holtedam 3, 3050 Humlebaek, Denmark

from 11.30 - 18.00 CEST (Central European Summer Time)



Coloplast invites institutional investors, equity analysts and media to attend our 2024 Meet the Management event.

The event will be held in person at our headquarters in Humlebaek, Denmark, with the option to join us virtually for the plenary session.

The purpose of the event is to provide participants with the opportunity to meet Coloplast’s Executive Management and other members of senior management.

The day will start with a plenary session, covering a brief presentation of our H1 2023/24 results, an update on our Strive25 strategy and a dedicated session on the recent acquisition of Kerecis. In the afternoon, participants will be split into groups and rotate between four Q&A breakout sessions. Participation in the breakout sessions will be in-person only.

The formal program will end at 18.00, followed by an opportunity to meet the Coloplast management team in an informal setting.



Agenda in CEST

11.00 - 11.30 Registration

11.30 - 13.00 Plenary session: H1 2023/24 results, Strive25 strategy update, Kerecis

13.00 - 13.50 Lunch break

13.50 - 18.00 Q&A breakout sessions (incl. breaks)

18.00 - 19.30 BBQ and drinks (on premise)



Coloplast representatives

Plenary session

Kristian Villumsen, President and CEO

Anders Lonning-Skovgaard, Executive Vice President and CFO

Fertram Sigurjonsson, Founder and CEO of Kerecis

Breakout sessions

- Innovation

Nicolai Buhl Andersen, Executive Vice President, Innovation

Anders Nørby, Senior Vice President, R&D

Steen Blaabjerg Morvan, Senior Vice President, Marketing & Services

Marie Smidt, Vice President, Bowel Management

- Growth

Paul Marcun, Executive Vice President, Growth

Manu Varma, Senior Vice President, North America Chronic Care

Johan Mastrell, Senior Vice President, Region UKI Chronic Care

- Interventional Urology, Voice & Respiratory Care and Adv. Wound Dressings

Thomas NP Johns Jr, Senior Vice President, Interventional Urology

Caroline Vagner Rosenstand, Senior Vice President, Voice & Respiratory Care

Jesper Johnsen Steen, Senior Vice President, Wound and Skin Care

- Global Operations, Sustainability and People & Culture

Allan Rasmussen, Executive Vice President, Global Operations

Camilla Hjort Pagh, Senior Vice President, Global QA, RA & Sustainability

Dorthe Rønnau, Senior Vice President, People & Culture 



In-person participation


If you wish to join us in person and attend the plenary session and the Q&A breakout sessions, please register by sending an email to  stating your full name, company, contact phone number and itinerary (if relevant).

Kindly register before Friday, 17 May 2024.

Virtual participation

Virtual participation will be possible for the plenary session.

A link for the webcast of the plenary sessions will be available on our website closer to the date.



For more information, please contact:

Aleksandra Dimovska, Sr. Director, IR

Direct tel.:

E-mail: 

Kristine Husted Munk, Sr. IR Manager

Direct tel.:

E-mail: 

Hannah Larsen, IR Coordinator

Direct tel.:

Email: 

Attachment



EN
16/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference...

Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST Tuesday, 19 August 2025 at 11.00 - 12.00h CESTIn connection with the publication of Coloplast’s interim financial results for 9M 2024/25, to be released same day in the morning around 07.30h CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available d...

 PRESS RELEASE

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 Sep...

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025 The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.The purpose of the event is to give institutional investors and financial analysts an introductio...

Coloplast AS: 1 director

A director at Coloplast AS bought 18,450 shares at 650.500DKK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

ResearchPool Subscriptions

Get the most out of your insights

Get in touch